71: Audit of the epidermal growth factor tyrosine kinase (EGFR) and anaplastic lymphoma kinase (ALK) mutation request pathway in non-squamous non-small cell lung cancer (NSCLC) in Kent. (January 2015) - Taylor, H.; Shah, R.; Mccormick, G.; Burcombe, R.; Beesley, S.; Cominos, M.; Hall, J.; Sevitt, T.